Drozitumab (TNFRSF10B/TRAILR2/CD262) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-349
Artikelname: Drozitumab (TNFRSF10B/TRAILR2/CD262) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-349
Hersteller Artikelnummer: 10-349
Alternativnummer: PRS-10-349-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Homo sapiens / TNFRSF10B/TRAILR2/CD262 [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: PRO95780,anti-DR5,rhuMAb DR5
Klonalität: Monoclonal
Konzentration: batch dependent
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.